CTSA Program Posters

The vibrant partnership between the UC Davis School of Medicine (SOM) and School of Veterinary Medicine (SVM) goes back to the inception of the medical school in 1972. The SVM is a premier veterinary school ranked 1st in federal funding. The UC Davis SOM is one of the fastest rising U.S. medical schools with regard to research and has advanced from 57th to 29th in NIH ranking since the inception

COVID-19 hit the Bronx, NY in March 2020 as our institution and the Northeast fell victim to the virus. The many teams that make up the programs of the Einstein-Montefiore Institute for Clinical and Translational Research (ICTR) responded quickly, not due to special foresight to anticipate such an acute worldwide crisis, but because our foundational philosophy is to use the ICTR as an integrated

CTSA resources are vital to our Hub’s efforts to understand SARS-CoV-2 infection and to prevent and treat COVID-19. In partnership with institutional leadership, our CTSA launched a rapid, multifaceted response protocol to advance the work of Pei-Yong Shi, PhD and his team, who had been working with the Galveston National Laboratory to develop a high throughput assay platform for neutralizing

Due to the volume and complexity of COVID-19 clinical trials, in the midst of staffing and resource limitations (e.g., PPE), we established a COVID-19 Clinical Trials Prioritization Committee as a vital part of the VCU/VCUHS combined efforts to address the COVID-19 pandemic. The goal of the committee was to facilitate and guide multidisciplinary efforts through transparent and high levels of

Moving scientific advances from the laboratory into clinical practice is a core element of translational research. NC TraCS has been committed to fostering the ultimate dissemination of translational research through commercialization and entrepreneurship since our initial funding in 2008 and continues to do so through FastTraCS. FastTraCS is our CTSA Optional Module that builds on previous NC

Building Capacity for Rapid COVID-19 Scientific Research Cheryl Dennison Himmelfarb RN PhD, Suzanne Jan de Beur MD, Cassie Lewis Land MS, Dan Ford MD MPH, Mark Sulkowski MD The Johns Hopkins Institute for Clinical and Translational Research, Johns Hopkins University, Baltimore, Maryland Background: The Johns Hopkins Health System (JHHS) and University has led a robust response to the COVID-19

SC CTSI leveraged its Community Engagement team’s existing work with Latinx communities and launched a workshop over Zoom specifically tailored to Latinx and Black/African American community members. To date we have delivered this course, in both Spanish and English, to over 400 Latinx participants. A retrospective pre/post evaluation has demonstrated changes in knowledge on COVID-19 transmission

Since 2009, we have promoted translational entrepreneurial activities at our CTSA Hub, with an emphasis on engaging scholars and trainees. We are building a culture of innovation and entrepreneurship, as a way to enhance discovery and translation of products that improve health. As an optional function of our second CTSA, we developed the Innovations in Molecular Therapeutics and Devices (IMTD)

The coronavirus disease 2019 (COVID-19) pandemic has challenged America’s public health infrastructure in a manner unseen in over a century. While some of the first hard-hit areas, such as New York City, are cautiously reporting declining case volumes, hospitalizations, and mortality rates, several states and urban areas are just now (mid-June) reporting new peaks, underscoring the unpredictable

The Institute of Translational Health Sciences (ITHS) at the University of Washington (UW) maintains a REDCap instance that has seen nearly exponential growth since its inception in 2009, making it one of the largest globally. We've been successful in operating that instance with a modest resource allocation and computational infrastructure. Before the pandemic, we had scaled to nearly 20k